JP2023531666A5 - - Google Patents

Info

Publication number
JP2023531666A5
JP2023531666A5 JP2022578853A JP2022578853A JP2023531666A5 JP 2023531666 A5 JP2023531666 A5 JP 2023531666A5 JP 2022578853 A JP2022578853 A JP 2022578853A JP 2022578853 A JP2022578853 A JP 2022578853A JP 2023531666 A5 JP2023531666 A5 JP 2023531666A5
Authority
JP
Japan
Prior art keywords
compound
liposome composition
liposome
composition according
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022578853A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023531666A (ja
JP7805319B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/038131 external-priority patent/WO2021258013A1/en
Publication of JP2023531666A publication Critical patent/JP2023531666A/ja
Publication of JP2023531666A5 publication Critical patent/JP2023531666A5/ja
Priority to JP2025172929A priority Critical patent/JP2026035569A/ja
Application granted granted Critical
Publication of JP7805319B2 publication Critical patent/JP7805319B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022578853A 2020-06-18 2021-06-18 オキサゾリジノン化合物、オキサゾリジノン化合物を含むリポソーム組成物、およびそれらの使用方法 Active JP7805319B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025172929A JP2026035569A (ja) 2020-06-18 2025-10-14 オキサゾリジノン化合物、オキサゾリジノン化合物を含むリポソーム組成物、およびそれらの使用方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063040810P 2020-06-18 2020-06-18
US63/040,810 2020-06-18
US17/351,631 2021-06-18
PCT/US2021/038131 WO2021258013A1 (en) 2020-06-18 2021-06-18 Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof
US17/351,631 US11555033B2 (en) 2020-06-18 2021-06-18 Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025172929A Division JP2026035569A (ja) 2020-06-18 2025-10-14 オキサゾリジノン化合物、オキサゾリジノン化合物を含むリポソーム組成物、およびそれらの使用方法

Publications (3)

Publication Number Publication Date
JP2023531666A JP2023531666A (ja) 2023-07-25
JP2023531666A5 true JP2023531666A5 (cg-RX-API-DMAC7.html) 2024-06-26
JP7805319B2 JP7805319B2 (ja) 2026-01-23

Family

ID=79025353

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022578853A Active JP7805319B2 (ja) 2020-06-18 2021-06-18 オキサゾリジノン化合物、オキサゾリジノン化合物を含むリポソーム組成物、およびそれらの使用方法
JP2025172929A Pending JP2026035569A (ja) 2020-06-18 2025-10-14 オキサゾリジノン化合物、オキサゾリジノン化合物を含むリポソーム組成物、およびそれらの使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025172929A Pending JP2026035569A (ja) 2020-06-18 2025-10-14 オキサゾリジノン化合物、オキサゾリジノン化合物を含むリポソーム組成物、およびそれらの使用方法

Country Status (10)

Country Link
US (7) US11555033B2 (cg-RX-API-DMAC7.html)
JP (2) JP7805319B2 (cg-RX-API-DMAC7.html)
KR (2) KR20250171477A (cg-RX-API-DMAC7.html)
AU (1) AU2021292747A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022025918A2 (cg-RX-API-DMAC7.html)
CA (1) CA3183397A1 (cg-RX-API-DMAC7.html)
IL (2) IL299155B2 (cg-RX-API-DMAC7.html)
MX (2) MX2022016063A (cg-RX-API-DMAC7.html)
WO (1) WO2021258013A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202300486B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021292747A1 (en) 2020-06-18 2023-02-23 Akagera Medicines, Inc. Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof
AR128071A1 (es) * 2021-12-22 2024-03-20 Akagera Medicines Inc Composiciones liposomales de oxazolidinona
EP4296674A1 (en) 2022-06-20 2023-12-27 Université Toulouse III - Paul Sabatier Innovative molecules decreasing virulence of mycobacterium for the treatment of tuberculosis
GB202210829D0 (en) * 2022-07-25 2022-09-07 Micropore Tech Ltd Continuous process

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085107B2 (ja) 1988-08-04 1996-01-24 ファナック株式会社 電動式射出成形機における位置決め方式
IL91664A (en) 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
KR950702417A (ko) 1992-07-08 1995-07-29 로렌스 티. 웰츠 마이코박테륨 투베르쿨로시스에 대해 유용한 5′-인돌리닐 옥사졸리디논(5′-indolinyl oxazolidinones useful against mycobacterium tuberculosis)
JPH0873455A (ja) 1994-03-15 1996-03-19 Upjohn Co:The オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
US5800833A (en) 1995-02-27 1998-09-01 University Of British Columbia Method for loading lipid vesicles
WO1998017256A1 (en) 1996-10-22 1998-04-30 Dmitri Kirpotin Compound-loaded liposomes and methods for their preparation
NZ522990A (en) * 2000-06-05 2003-08-29 Dong A Pharm Novel oxazolidinone derivatives and a process for the preparation thereof
WO2003008389A1 (en) 2001-07-16 2003-01-30 Ranbaxy Laboratories Limited Oxazolidinone derivatives as potential antimicrobials
WO2002006278A1 (en) 2000-07-17 2002-01-24 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
EP1432403B1 (en) 2001-10-03 2010-07-28 Celator Pharmaceuticals, Inc. Liposome loading with metal ions
AU2003230600B2 (en) * 2002-03-05 2009-06-04 Transave, Inc. An inhalation system for prevention and treatment of intracellular infections
CA2483600A1 (en) 2002-05-15 2003-11-27 Ranbaxy Laboratories Limited Polymorphic forms of phenyl oxazolidinone derivatives
BR0215921A (pt) 2002-07-29 2005-09-13 Ranbaxy Lab Ltd Derivados de oxazolidinona utilizáveis como antimicrobianos e processo de sua preparação
CA2507628A1 (en) 2002-11-28 2004-06-10 Astrazeneca Ab Oxazolidinones as antibacterial agents
GB0229518D0 (en) 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
AU2003223034A1 (en) 2003-05-06 2004-11-26 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
TWI378092B (en) 2003-06-03 2012-12-01 Rib X Pharmaceuticals Inc Biaryl heterocyclic compounds and methods of making and using the same
KR100854211B1 (ko) * 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
WO2005082899A1 (en) 2004-01-28 2005-09-09 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
KR101462825B1 (ko) 2004-05-03 2014-11-21 헤르메스 바이오사이언스, 인코포레이티드 약물 전달에 유용한 리포좀
CA2566963A1 (en) 2004-05-25 2005-12-08 Astrazeneca Ab 3-[4-{6-substituted alkanoyl pyridin-3-yl}-3-phenyl]-5-(1h-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-ones as antibacterial agents
JP2008500318A (ja) 2004-05-25 2008-01-10 アストラゼネカ アクチボラグ 抗菌剤としての3−{4−(ピリジン−3−イル)フェニル}−5−(1h−1,2,3−トリアゾール−1−イルメチル)−1,3−オキサゾリジン−2−オン
WO2006035283A1 (en) 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
CN101072588B (zh) 2004-10-06 2012-11-28 不列颠哥伦比亚抗癌机构 用于治疗癌症的具有改善的药物保留的脂质体
WO2006051408A1 (en) 2004-11-11 2006-05-18 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
EP1745784A1 (en) 2005-06-27 2007-01-24 Ferrer Internacional, S.A. Oxazolidinone derivatives and use thereof as antibiotics
ES2798263T3 (es) * 2005-12-08 2020-12-10 Insmed Inc Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
KR101023174B1 (ko) 2008-09-24 2011-03-18 주식회사 레고켐 바이오사이언스 사이클릭 아미독심 또는 사이클릭 아미드라존 기를 가지는 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물
RU2659792C1 (ru) 2008-10-10 2018-07-04 Мерк Шарп Энд Домэ Корп. Оксазолидиноны и способ их очистки
MX384300B (es) 2009-02-03 2025-03-14 Merck Sharp & Dohme Llc Forma cristalina del fosfato de dihidrogeno r) -3- (4- (2- (2-metiltetrazol-5-il) piridin-5-il) -3-fluorofenil) -5-hidroximetil oxazolidin-2-ona.
US8580767B2 (en) 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
US20120065170A1 (en) 2010-09-10 2012-03-15 Micurx Pharmaceuticals, Inc. Antimicrobial Cyclocarbonyl Heterocyclic Compounds For Treatment Of Bacterial Infections
HK1199250A1 (en) 2011-09-29 2015-06-26 山东轩竹医药科技有限公司 Biaryl heterocycle substituted oxazolidinon antibacterial drug
WO2016009401A2 (en) 2014-07-18 2016-01-21 Dr. Reddy's Laboratories Limited Preparation of tedizolid phosphate
WO2016041505A1 (zh) 2014-09-17 2016-03-24 正大天晴药业集团股份有限公司 一种磷酸特地唑胺、其中间体以及它们的制备方法
CN106928214A (zh) 2014-09-17 2017-07-07 博瑞生物医药(苏州)股份有限公司 一种噁唑烷酮类化合物及其中间体的制备方法
CN104327119A (zh) 2014-10-17 2015-02-04 苏州明锐医药科技有限公司 磷酸泰地唑胺的制备方法
WO2016088100A1 (en) 2014-12-05 2016-06-09 Sun Pharmaceutical Industries Limited Processes for the preparation of tedizolid phosphate and its intermediates
WO2016088103A1 (en) 2014-12-05 2016-06-09 Sun Pharmaceutical Industries Limited A process for the preparation of tedizolid phosphate
WO2016088101A1 (en) 2014-12-05 2016-06-09 Sun Pharmaceutical Industries Limited Processes for the preparation of tedizolid phosphate and its intermediates
WO2016088102A1 (en) 2014-12-05 2016-06-09 Sun Pharmaceutical Industries Limited Processes for the preparation of tedizolid phosphate and its intermediates
EP3347008B1 (en) 2015-09-11 2022-03-09 Venatorx Pharmaceuticals, Inc. Beta-lactamase inhibitors
ES3036518T3 (en) 2015-10-16 2025-09-19 Ipsen Biopharm Ltd Stabilizing camptothecin pharmaceutical compositions
WO2017066964A1 (en) 2015-10-22 2017-04-27 Merck Sharp & Dohme Corp. Oxazolidinone compounds and methods of use thereof as antibacterial agents
CN106632298B (zh) 2015-11-03 2021-06-01 上海科胜药物研发有限公司 一种泰地唑胺的制备方法及其中间体
KR101855334B1 (ko) 2015-12-11 2018-06-08 에스티팜 주식회사 옥사졸리디논 유도체의 중간체 제조방법
WO2017100925A1 (en) 2015-12-15 2017-06-22 British Columbia Cancer Agency Branch Metal complexed therapeutic agents and lipid-based nanoparticulate formulations thereof
EP3936153B1 (en) 2016-01-11 2024-08-21 Celator Pharmaceuticals, Inc. Inhibiting ataxia telangiectasia and rad3-related protein (atr)
WO2017143112A2 (en) 2016-02-17 2017-08-24 The Johns Hopkins University An oxazolidinone for treatment of infections with mycobacterium tuberculosis
WO2018170664A1 (en) 2017-03-20 2018-09-27 Merck Sharp & Dohme Corp. Oxazolidinone compounds and methods of use thereof as antibacterial agents
US12109203B2 (en) 2018-07-25 2024-10-08 Zydus Lifesciences Limited Substituted oxazolidinones for the treatment of mammalian infections
EP3914587A4 (en) 2019-01-18 2022-11-23 Merck Sharp & Dohme LLC OXAZOLIDINONE COMPOUNDS AND USES THEREOF AS ANTIBACTERIAL AGENTS
WO2021184339A1 (en) 2020-03-20 2021-09-23 Merck Sharp & Dohme Corp. Oxazolidinone compound and methods of use thereof as an antibacterial agent
AU2021292747A1 (en) 2020-06-18 2023-02-23 Akagera Medicines, Inc. Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof

Similar Documents

Publication Publication Date Title
IL299155B1 (en) Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof
EP1750673B1 (en) Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
EP0825852B1 (en) Liposome drug-loading method and composition
EP1083881B1 (en) LIPOSOME COMPOSITIONs containing a quinolone derivative AND their use as antibacterial agents
CN102223878A (zh) 包含鞘磷脂的脂质体系统
CA2584279C (en) Compositions and methods for stabilizing liposomal drug formulations
JP2021522163A5 (cg-RX-API-DMAC7.html)
IL278079B2 (en) Inhalable liposomal sustained release composition for use in treating pulmonary diseases
EP1567130A2 (en) Method of drug loading in liposomes by gradient
WO1999013865A1 (en) Sustained-release liposomal anesthetic compositions
WO2012117385A2 (en) Liposome formulation comprising an anti-tumour active substance, method for its preparation and pharmaceutical compositions comprising it
TWI767133B (zh) 含有治療憂鬱症或焦慮症之治療劑的緩釋組合物及其用途
TWI755629B (zh) 含鎮靜藥物之緩釋藥物組合物及其用途
WO2007049278A2 (en) A method for preparing liposomes and uses thereof
JP2022500398A5 (cg-RX-API-DMAC7.html)
WO2025012723A1 (en) Liposome encapsulated apomorphine
WO2017074475A1 (en) Stable liposomal formulations of alpha 2 adrenergic agonists for ocular delivery
JP2025501769A5 (cg-RX-API-DMAC7.html)
TWI853932B (zh) 用於治療肺部疾病之可吸入的支氣管擴張劑緩釋組成物
KR20240152302A (ko) 옥사졸리디논 리포좀 조성물
TWI767149B (zh) 含有免疫調節劑的緩釋藥物組合物及其用途
RU2791481C2 (ru) Анестетические композиции с замедленным высвобождением и способы их получения
TWI850208B (zh) 緩釋型翠普登組成物及其經皮下或類似途徑使用之方法
JP2022505378A5 (cg-RX-API-DMAC7.html)
BR102017018582B1 (pt) Lipossomas, processo de obtenção, composições antitumorais e usos